BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33684631)

  • 1. Derivation of iPSC line (RCMGi002-A) from dermal fibroblasts of a cystic fibrosis female patient with homozygous F508del mutation.
    Kondrateva E; Demchenko A; Slesarenko Y; Yasinovsky M; Amelina E; Tabakov V; Voronina E; Lavrov A; Smirnikhina S
    Stem Cell Res; 2021 May; 53():102251. PubMed ID: 33684631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of two induced pluripotent stem cell lines (RCMGi004-A and -B) from human skin fibroblasts of a cystic fibrosis patient with compound heterozygous F508del/W1282X mutations in CFTR gene.
    Kondrateva E; Demchenko A; Slesarenko Y; Pozhitnova V; Yasinovsky M; Amelina E; Tabakov V; Voronina E; Lavrov A; Smirnikhina S
    Stem Cell Res; 2021 Apr; 52():102232. PubMed ID: 33607467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of induced pluripotent stem cell line (RCMGi001-A) from human skin fibroblasts of a cystic fibrosis patient with p.F508del mutation.
    Kondrateva E; Adilgereeva E; Amelina E; Tabakov V; Demchenko A; Ustinov K; Yasinovsky M; Voronina E; Lavrov A; Smirnikhina S
    Stem Cell Res; 2020 Oct; 48():101933. PubMed ID: 32777768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of induced pluripotent stem cell line (RCMGi008-A) from human skin fibroblasts of a cystic fibrosis patient with compound heterozygous F508del/CFTRdele2.3 mutations in CFTR gene.
    Kondrateva E; Panchuk I; Demchenko A; Grigorieva O; Zheglo D; Voronina E; Erofeeva A; Tabakov V; Orlova M; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2022 Aug; 63():102854. PubMed ID: 35843019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of two induced pluripotent stem cell (iPSC) lines from p.F508del Cystic Fibrosis patients.
    Fleischer A; Lorenzo IM; Palomino E; Aasen T; Gómez F; Servera M; Asensio VJ; Gálvez V; Izpisúa-Belmonte JC; Bachiller D
    Stem Cell Res; 2018 May; 29():1-5. PubMed ID: 29554588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of two induced pluripotent stem cell lines (RCMGi005-A/B) from human skin fibroblasts of a cystic fibrosis patient with homozygous F508del mutation in CFTR gene.
    Panchuk I; Kondrateva E; Demchenko A; Grigorieva O; Erofeeva A; Amelina E; Tabakov V; Orlova M; Voronina E; Pozhitnova V; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2022 Oct; 64():102896. PubMed ID: 36067639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of an induced pluripotent stem cell line (IGGi002A) from nasal cells of a cystic fibrosis patient homozygous for the G542X-CFTR mutation.
    Dębczyński M; Mojsak D; Tamburro S; Baldassari S; Musante I; Casciaro R; Ciciriello F; Zara F; Scudieri P; Gorrieri G
    Stem Cell Res; 2023 Oct; 72():103232. PubMed ID: 37865062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of induced pluripotent stem cell line (RCMGi012-A) from fibroblasts of patient with mucopolysaccharidosis type VI.
    Kondrateva E; Grigorieva O; Panchuk I; Bychkov I; Zakharova E; Tabakov V; Pozhitnova V; Voronina E; Shchagina O; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2023 Dec; 73():103259. PubMed ID: 38006675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An induced pluripotent stem cell line (CSUi004-A) from skin fibroblasts of a healthy individual.
    Wang L; Zhao H; Wu J; Ren J; Luo H; Zuo X; Chen Q; Tang Y
    Stem Cell Res; 2021 May; 53():102336. PubMed ID: 33865102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear reprogramming with a non-integrating human RNA virus.
    Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
    Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation of human induced pluripotent stem cell line (HUSTi001-A) from a 40-year-old patient with idiopathic infertility.
    Fang F; Li Z; Zhao Q; Ye Z; Zhao K; Gu X; Shen S; Reijo Pera RA; Xiong C
    Stem Cell Res; 2018 Mar; 27():136-139. PubMed ID: 29414604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of induced pluripotent stem cell line NIMHi010-A from dermal fibroblast cells of a healthy individual.
    Dash SS; Arunachal G; Nimonkar MM; Vengalil S; Nashi S; Chetan GK; Boddu VK; Nalini A; Markandeya YS
    Stem Cell Res; 2024 Apr; 76():103355. PubMed ID: 38412659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7.
    Chen ZT; Zhao ZH; Chen LN; Fan F; Cai GE; Weng HD; Wang YQ; Liao LM; Chen XC; Huang E; Ye QY
    Stem Cell Res; 2021 Mar; 51():102175. PubMed ID: 33485186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of induced pluripotent stem cell line (RCMGi009-A) from urine cells of patient with fibrodysplasia ossificans progressiva.
    Kondrateva E; Grigorieva O; Kurshakova E; Panchuk I; Pozhitnova V; Voronina E; Tabakov V; Orlova M; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2023 Aug; 70():103133. PubMed ID: 37307755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of two hiPSC lines (IIMCBi001-A and IIMCBi002-A) from dermal fibroblasts of healthy donors and characterization of their cell cycle.
    Liszewska E; Majchrowicz L; Krogulec E; Kotulska K; Kaczmarek L; Kalita K; Dobrzyń A; Jaworski J
    Stem Cell Res; 2021 Apr; 52():102225. PubMed ID: 33588215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a pig induced pluripotent stem cell (piPSC) line from embryonic fibroblasts by incorporating LIN28 to the four transcriptional factor-mediated reprogramming: VSMUi001-D.
    Chakritbudsabong W; Sariya L; Pamonsupornvichit S; Pronarkngver R; Chaiwattanarungruengpaisan S; Ferreira JN; Setthawong P; Phakdeedindan P; Techakumphu M; Tharasanit T; Rungarunlert S
    Stem Cell Res; 2017 Oct; 24():21-24. PubMed ID: 29034889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.